199 related articles for article (PubMed ID: 18378390)
21. Methylation status of fragile histidine triad (FHIT) gene and its clinical impact on prognosis of patients with myelodysplastic syndrome.
Lin J; Yao DM; Qian J; Wang YL; Han LX; Jiang YW; Fei X; Cen JN; Chen ZX
Leuk Res; 2008 Oct; 32(10):1541-5. PubMed ID: 18367246
[TBL] [Abstract][Full Text] [Related]
22. Understanding the mechanisms of FHIT inactivation in cervical cancer for biomarker development.
Lea JS; Ashfaq R; Muneer S; Burbee DG; Miller DS; Minna JD; Muller CY
J Soc Gynecol Investig; 2004 Jul; 11(5):329-37. PubMed ID: 15219888
[TBL] [Abstract][Full Text] [Related]
23. Different genetic pathways in the development of periocular sebaceous gland carcinomas in presumptive Muir-Torre syndrome patients.
Goldberg M; Rummelt C; Foja S; Holbach LM; Ballhausen WG
Hum Mutat; 2006 Feb; 27(2):155-62. PubMed ID: 16395674
[TBL] [Abstract][Full Text] [Related]
24. [Clinicopathological significance of aberrant methylation of the fragile histidine triad gene in patients with hepatocellular carcinoma].
Sun Y; Geng XP; Zhu LX; Xiong QR; Qian YB; Dong GY; Li XM
Zhonghua Wai Ke Za Zhi; 2006 May; 44(9):609-12. PubMed ID: 16784654
[TBL] [Abstract][Full Text] [Related]
25. [The effect of FHIT gene on renal cell carcinomas].
Chen X; Shen PF; Chen ZC
Hunan Yi Ke Da Xue Xue Bao; 2000 Oct; 25(5):457-9. PubMed ID: 12212117
[TBL] [Abstract][Full Text] [Related]
26. Hypermethylation patterns in the Fhit regulatory region are tissue specific.
Guler G; Iliopoulos D; Han SY; Fong LY; Lubet RA; Grubbs CJ; Huebner K
Mol Carcinog; 2005 Jul; 43(3):175-81. PubMed ID: 15937960
[TBL] [Abstract][Full Text] [Related]
27. FHIT expression in clear cell renal carcinomas: versatility of protein levels and correlation with survival.
Ramp U; Caliskan E; Ebert T; Karagiannidis C; Willers R; Gabbert HE; Gerharz CD
J Pathol; 2002 Apr; 196(4):430-6. PubMed ID: 11920739
[TBL] [Abstract][Full Text] [Related]
28. Different immunohistochemical patterns of Fhit protein expression in renal neoplasms.
Eyzaguirre EJ; Miettinen M; Norris BA; Gatalica Z
Mod Pathol; 1999 Oct; 12(10):979-83. PubMed ID: 10530564
[TBL] [Abstract][Full Text] [Related]
29. [Two CpG-islands of SEMA3B gene: methylation in clear cell renal cell carcinoma].
Loginov VI; Khodyrev DS; Pronina IV; Maliukova AV; Kazubskaia TP; Ermilova VD; Gar'kavtseva RF; Zabarovskiĭ ER; Braga EA
Mol Biol (Mosk); 2009; 43(6):1088-92. PubMed ID: 20088387
[TBL] [Abstract][Full Text] [Related]
30. Downregulation of EphA7 by hypermethylation in colorectal cancer.
Wang J; Kataoka H; Suzuki M; Sato N; Nakamura R; Tao H; Maruyama K; Isogaki J; Kanaoka S; Ihara M; Tanaka M; Kanamori M; Nakamura T; Shinmura K; Sugimura H
Oncogene; 2005 Aug; 24(36):5637-47. PubMed ID: 16007213
[TBL] [Abstract][Full Text] [Related]
31. Promoter hypermethylation profile of RASSF1A, FHIT, and sFRP1 in intracranial primitive neuroectodermal tumors.
Chang Q; Pang JC; Li KK; Poon WS; Zhou L; Ng HK
Hum Pathol; 2005 Dec; 36(12):1265-72. PubMed ID: 16311119
[TBL] [Abstract][Full Text] [Related]
32. Reduced acetylated histone H4 is associated with promoter methylation of the fragile histidine triad gene in resected esophageal squamous cell carcinoma.
Tzao C; Sun GH; Tung HJ; Hsu HS; Hsu WH; Wang YC; Cheng YL; Lee SC
Ann Thorac Surg; 2006 Aug; 82(2):396-401; discussion 401. PubMed ID: 16863736
[TBL] [Abstract][Full Text] [Related]
33. Hypermethylation of the CpG island of connexin 32, a candiate tumor suppressor gene in renal cell carcinomas from hemodialysis patients.
Yano T; Ito F; Kobayashi K; Yonezawa Y; Suzuki K; Asano R; Hagiwara K; Nakazawa H; Toma H; Yamasaki H
Cancer Lett; 2004 May; 208(2):137-42. PubMed ID: 15142671
[TBL] [Abstract][Full Text] [Related]
34. About the origin and development of hereditary conventional renal cell carcinoma in a four-generation t(3;8)(p14.1;q24.23) family.
Valle L; Cascón A; Melchor L; Otero I; Rodríguez-Perales S; Sánchez L; Cruz Cigudosa J; Robledo M; Weber B; Urioste M; Benítez J
Eur J Hum Genet; 2005 May; 13(5):570-8. PubMed ID: 15756303
[TBL] [Abstract][Full Text] [Related]
35. Molecular analysis of the fragile histidine triad (FHIT) tumor suppressor gene in vesical tumors of cattle with chronic enzootic hematuria (CEH).
Guidi E; Uboldi C; Ferretti L
Cytogenet Genome Res; 2008; 120(1-2):173-7. PubMed ID: 18467844
[TBL] [Abstract][Full Text] [Related]
36. The FHIT gene is alternatively spliced in normal kidney and renal cell carcinoma.
Luan X; Shi G; Zohouri M; Paradee W; Smith DI; Decker HJ; Cannizzaro LA
Oncogene; 1997 Jul; 15(1):79-86. PubMed ID: 9233780
[TBL] [Abstract][Full Text] [Related]
37. Methylation-associated silencing of SFRP1 in renal cell carcinoma.
Awakura Y; Nakamura E; Ito N; Kamoto T; Ogawa O
Oncol Rep; 2008 Nov; 20(5):1257-63. PubMed ID: 18949430
[TBL] [Abstract][Full Text] [Related]
38. [P15(INK4B) gene methylation in malignant hematopoietic diseases].
Wu Q; Guo X; Fan H; Zhou T; Tan G; Guo Q; Chen P; Zhang X; Luo G; Xu M
Zhonghua Xue Ye Xue Za Zhi; 2000 Dec; 21(12):644-6. PubMed ID: 11877040
[TBL] [Abstract][Full Text] [Related]
39. CpG methylation in the Fhit regulatory region: relation to Fhit expression in murine tumors.
Han SY; Iliopoulos D; Druck T; Guler G; Grubbs CJ; Pereira M; Zhang Z; You M; Lubet RA; Fong LY; Huebner K
Oncogene; 2004 May; 23(22):3990-8. PubMed ID: 15007387
[TBL] [Abstract][Full Text] [Related]
40. [Hypermethylation of fragile histidine triad gene and 3p14 allelic deletion in ovarian carcinomas].
Hong FZ; Wang B; Li HM; Liew CT
Zhonghua Bing Li Xue Za Zhi; 2005 May; 34(5):257-61. PubMed ID: 16181544
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
